Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587587 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids
A Phase 1 study, sponsored by Organogenesis.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00587587 is a Phase 1 study that has completed, run by Organogenesis. The registered enrollment target is 30 participants.
The verdict
NCT00587587, a Phase 1 study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This pilot study will assess the safety and efficacy of Apligraf in the healing and recurrence of keloids post surgical shave excision in patients with clinically diagnosed keloids.
Interventions
- DEVICE Apligraf
- OTHER Standard dressing regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587587
The ClinicalTrials.gov registry entry for NCT00587587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Apligraf is the first listed.
NCT00587587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587587 about?
NCT00587587 is a clinical study titled "A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids". This pilot study will assess the safety and efficacy of Apligraf in the healing and recurrence of keloids post surgical shave excision in patients with clinically diagnosed keloids.
What is the current status of trial NCT00587587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2007-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00587587?
The interventions under investigation include: Apligraf (DEVICE), Standard dressing regimen (OTHER).
Who is sponsoring clinical trial NCT00587587?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.